EFFECT OF MUTATIONS IN THE V3 LOOP OF HIV-1 GP120 ON INFECTIVITY AND SUSCEPTIBILITY TO PROTEOLYTIC CLEAVAGE

被引:36
作者
SCHULZ, TF
REEVES, JD
HOAD, JG
TAILOR, C
STEPHENS, P
CLEMENTS, G
ORTLEPP, S
PAGE, KA
MOORE, JP
WEISS, RA
机构
[1] CELLTECH LTD,SLOUGH,BERKS,ENGLAND
[2] UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1089/aid.1993.9.159
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been suggested that the V3 domain of human immunodeficiency virus type 1 (HIV-1) isolates has to interact with a cell-surface-associated or endosomal proteinase during virus entry into susceptible cells. To investigate this hypothesis, we examined the effect of several mutations in the V3 loop on its susceptibility to proteolytic cleavage by thrombin and cathepsin E and compared it with the effect of these mutations on viral infectivity. The data obtained indicate that, if an interaction between the V3 loop and a proteinase is indeed crucial for viral entry, the substrate requirements for such a proteinase(s) would have to be very complex. In particular, it seems unlikely that a single enzyme with a unique specificity would be able to interact with all of the different HIV-1 and HIV-2/SIV strains isolated so far. Therefore, one would have to postulate the involvement of several cellular proteinases, or proteases with multiple specificities, in V3-based viral tropism.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 48 条
[1]   CLEAVAGE FRAGMENTS OF THE RETROVIRUS SURFACE PROTEIN-GP70 DURING VIRUS ENTRY [J].
ANDERSEN, KB .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2193-2202
[2]   HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN CD4-MEDIATED FUSION OF NONPRIMATE CELLS WITH HUMAN-CELLS [J].
ASHORN, PA ;
BERGER, EA ;
MOSS, B .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2149-2156
[3]   BIOLOGICAL PROPERTIES OF A CD4 IMMUNOADHESIN [J].
BYRN, RA ;
MORDENTI, J ;
LUCAS, C ;
SMITH, D ;
MARSTERS, SA ;
JOHNSON, JS ;
COSSUM, P ;
CHAMOW, SM ;
WURM, FM ;
GREGORY, T ;
GROOPMAN, JE ;
CAPON, DJ .
NATURE, 1990, 344 (6267) :667-670
[4]   SPECIFIC CELL-SURFACE REQUIREMENTS FOR THE INFECTION OF CD4-POSITIVE CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND BY SIMIAN IMMUNODEFICIENCY VIRUS [J].
CLAPHAM, PR ;
BLANC, D ;
WEISS, RA .
VIROLOGY, 1991, 181 (02) :703-715
[5]   THE V3 LOOPS OF THE HIV-1 AND HIV-2 SURFACE GLYCOPROTEINS CONTAIN PROTEOLYTIC CLEAVAGE SITES - A POSSIBLE FUNCTION IN VIRAL FUSION [J].
CLEMENTS, GJ ;
PRICEJONES, MJ ;
STEPHENS, PE ;
SUTTON, C ;
SCHULZ, TF ;
CLAPHAM, PR ;
MCKEATING, JA ;
MCCLURE, MO ;
THOMSON, S ;
MARSH, M ;
KAY, J ;
WEISS, RA ;
MOORE, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (01) :3-16
[6]   RAT MONOCLONAL-ANTIBODIES TO NONOVERLAPPING EPITOPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 BLOCK CD4 BINDING INVITRO [J].
CORDELL, J ;
MOORE, JP ;
DEAN, CJ ;
KLASSE, PJ ;
WEISS, RA ;
MCKEATING, JA .
VIROLOGY, 1991, 185 (01) :72-79
[7]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY [J].
DEJONG, JJ ;
GOUDSMIT, J ;
KEULEN, W ;
KLAVER, B ;
KRONE, W ;
TERSMETTE, M ;
DERONDE, A .
JOURNAL OF VIROLOGY, 1992, 66 (02) :757-765
[9]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[10]   IDENTIFICATION OF THE PRINCIPAL NEUTRALIZING DETERMINANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS A FUSION DOMAIN [J].
FREED, EO ;
MYERS, DJ ;
RISSER, R .
JOURNAL OF VIROLOGY, 1991, 65 (01) :190-194